5 European Projects Found
Searched on 125080 European Projects
FINISHED
A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 or MEK-162 with cMET inhibitor PF-02341066 in RASMT and RASWT (with aberrant c-MET) Colorectal Cancer Patients (MERCURIC)
Start date: Dec 1, 2013, End date: Nov 30, 2020,
Colorectal cancer (CRC) is the 3rd most common cancer in Europe, and with approximately 200,000 deaths per year, it remains the 2nd most common cause of cancer death. More than half of all CRC patients develop distant metastases and have 5-year overall survival (OS) of less than 5% because of ineffective treatments. Increased understanding of cancer biology, coupled with the implementation of “omi ...
Read Project
13
Partners Participants
FINISHED
Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population (BESTAGEING)
Start date: Feb 1, 2013, End date: Jan 31, 2018,
The ageing of the European population represents a rapidly rising social and economic challenge. Especially cardiovascular morbidity increases with age, but unfortunately, elderly patients are often difficult to diagnose due to confounding factors, leading to uncertainties in clinical decision making with huge impact on patients’ outcomes. Hence, there is an unmet need for novel biomarkers for mor ...
Read Project
22
Partners Participants
FINISHED
European Consortium for High-Throughput Research in Rare Kidney Diseases (EURENOMICS)
Start date: Oct 1, 2012, End date: Sep 30, 2017,
EURenOmics will integrate several established consortia devoted to rare kidney diseases with eminent need and potential for diagnostic and therapeutic progress (i.e. steroid resistant nephrotic syndrome, membranous nephropathy, tubulopathies, complement disorders such a haemolytic uraemic syndrome, and congenital kidney malformations). The Consortium has access to the largest clinical cohorts asse ...
Read Project
29
Partners Participants
FINISHED
A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches (EUROSTAM)
Start date: Dec 1, 2012, End date: Nov 30, 2015,
The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and often die on the transplant waiting lists as it is almost impossible to find donors towards which they don’t have antibodies. The acceptable mismatch program of Eurotransplant has shown to be an effective tool to enhance successful transplantation of highly sens ...
Read Project
11
Partners Participants
FINISHED
Validation of diagnostic and/or prognostic miRNAs in triple-negative breast cancer (MIRCAB)
Start date: Jan 1, 2015, End date: Jun 30, 2015,
Multiplicom will draft a business plan that is composed of the following parts:(i) selection of miRNAs for which there is substantial scientific evidence that such may be important for the diagnosis, treatment and/or prognosis of triple-negative breast cancer (“TNBC”) patients;(ii) perform a thorough analysis of the intellectual property on the selected miRNAs;(iii) start in-licensing negotiations ...
Read Project
